{"organizations": [], "uuid": "39690d1fe19e433e3166ffb86bd2e8dcfecf24ec", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "in.reuters.com", "main_image": "https://s4.reutersmedia.net/resources/r/?m=02&d=20180412&t=2&i=1250579421&w=1200&r=LYNXMPEE3B09T", "site_section": "http://feeds.reuters.com/reuters/INhealth\r", "section_title": "Reuters: Health", "url": "https://in.reuters.com/article/us-sanofi-canada/healthcare-group-sanofi-to-invest-350-million-euros-in-canada-vaccine-facility-idINKBN1HJ0K2", "country": "US", "domain_rank": 408, "title": "Healthcare group Sanofi to invest 350 million euros in Canada vaccine facility", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-12T08:29:00.000+03:00", "replies_count": 0, "uuid": "39690d1fe19e433e3166ffb86bd2e8dcfecf24ec"}, "author": "", "url": "https://in.reuters.com/article/us-sanofi-canada/healthcare-group-sanofi-to-invest-350-million-euros-in-canada-vaccine-facility-idINKBN1HJ0K2", "ord_in_thread": 0, "title": "Healthcare group Sanofi to invest 350 million euros in Canada vaccine facility", "locations": [], "entities": {"persons": [], "locations": [{"name": "canada", "sentiment": "none"}, {"name": "paris", "sentiment": "none"}, {"name": "ontario", "sentiment": "none"}, {"name": "paris", "sentiment": "none"}, {"name": "toronto", "sentiment": "none"}], "organizations": [{"name": "sanofi", "sentiment": "negative"}, {"name": "healthcare", "sentiment": "negative"}, {"name": "reuters staff", "sentiment": "none"}, {"name": "sanofi pasteur", "sentiment": "none"}, {"name": "ablynx", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 12, 2018 / 5:32 AM / Updated 6 hours ago Healthcare group Sanofi to invest 350 million euros in Canada vaccine facility Reuters Staff 1 Min Read \nPARIS (Reuters) - French healthcare group Sanofi ( SASY.PA ) is investing 350 million euros ($432.4 million) in a Canadian vaccine facility, which the drugmaker said would help it meet growing demand in this area. FILE PHOTO: A logo is seen in front of the entrance at the headquarters French drugmaker Sanofi in Paris October 30, 2014. REUTERS/Christian Hartmann/File Photo \nSanofiâ€™s new investment will finance the construction of a new state-of-the-art vaccine manufacturing facility at the Sanofi Pasteur Canadian headquarters in Toronto, Ontario. \nThe new facility would allow its Sanofi Pasteur division to meet the growing demand of five-component acellular pertussis (5-acP) antigen, the company added. \nSanofi sealed two major takeovers at the start of 2018, buying hemophilia specialist Bioverativ for $11.6 billion and acquiring Ablynx, which is developing a prized experimental drug for a rare blood disorder, for 3.9 billion euros ($4.8 billion). Reporting by Sudip Kar-Gupta; Editing by Sunil Nair", "external_links": [], "published": "2018-04-12T08:29:00.000+03:00", "crawled": "2018-04-12T09:07:01.084+03:00", "highlightTitle": ""}